Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Acquisition/DispositionItem 2.01 · 8-KLOW RiskPositive

Artivion, Inc.

cryolife.com
Filed: May 18, 2026AtlantaCIK: 0000784199Healthcare
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Artivion, Inc. completed its acquisition of Endospan Ltd., an Israeli medical device company specializing in aortic instability treatments, to expand its cardiovascular product portfolio and market position in the medical device sector.

Key Takeaways

Acquisition of Endospan Ltd. is now complete as of May 18, 2026, adding the Nexus™ product line to Artivion's portfolio

Endospan specializes in innovative products for treating aortic instability, strengthening Artivion's cardiovascular care offerings

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMay 18, 2026
Item2.01
CategoryAcquisition/Disposition
CIK0000784199
Accession #20260518
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
acquisitionexpansionproduct launch

What This Means

The company completed a major acquisition or sold off a significant asset. This reshapes the company's portfolio and strategic direction.
View Full Filing on SEC.govBrowse More Filings